Viruses are no longer used merely as naturally occurring tools for gene transfer or as blunt cytolytic agents. Researchers are rewriting their genomes, capsids, tropisms, regulatory elements, and payloads to create therapeutic systems that sense disease, execute conditional programs, and remodel pathological tissue. In...
Rawan H. Alsharedeh, A. Aljabali, M. Obeid et al.· RSC Advances· 0 citations
Diabetes mellitus is a global health issue with escalating metabolic dysfunction, clinical heterogeneity, and rising microvascular and macrovascular consequences. Traditional diabetes diagnosis, risk assessment, treatment selection, and complication surveillance rely on periodic clinical measures and population-level r...
Yachana Mishra, R. Kanday, Simran Kauts et al.· Current Diabetes Reviews· 0 citations
Simple Summary Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary immunotherapy that engineers a patient’s own immune T cells to specifically target and destroy malignant cells in hematological malignancies. This approach has transformed the treatment of relapsed acute lymphoblastic leukemia, lymphomas,...
Alaa A. A. Aljabali, Mohammad A. Obeid, A. Alqudah et al.· Cancers· 0 citations
Gastrodin may have a protective activity against CP cardiotoxicity, primarily by restoring redox balance/energy status, suppressing inflammation and apoptosis, and modulating p62–Keap1–Nrf2 related gene expression.
A. Alqudah, E. Qnais, Yousra Bsieso et al.· Molecular Biology Reports· 0 citations
This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.
Yachana Misha, Radheshyam Jena, Aman Shukla et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.